Gastrointestinal Cancer

6:09
DELIVER: nivolumab in advanced gastric cancer
Yu Sunakawa
2:11
Poverty amongst people diagnosed with cancer in the UK
Laura Woods
1:19
ILOC: synergism of immunomodulation and tumour ablation in CRC
Thibaud Kössler
4:28
PROOF: infigratinib as first-line therapy in patients with advanced CCA
Ghassan Abou-Alfa
1:29
ClarIDHy: ivosidenib in CCA
Ghassan Abou-Alfa
3:33
ESMO WCGIC: highlights in HCC
Ghassan Abou-Alfa
7:47
Combination tremelimumab and durvalumab in HCC
Bruno Sangro
1:18
PEMREC: neo-adjuvant pembrolizumab and RT in rectal cancer
Thibaud Kössler
5:49
Updates from CheckMate 459
Bruno Sangro
2:31
Efficacy of second-line chemotherapy in advanced CCA with FGFR2 fusions
Milind Javle
1:45
PROOF 301: infigratinib in advanced CCA
Milind Javle
1:14
Changes in the management of bilary tract cancer
Milind Javle
1:43
Nivolumab, ipilimumab and panitumumab in mCRC
Stacey Cohen
1:32
Impact of p-mTOR expression on molecular-guided therapy in PDAC
Hossein Taghizadeh
2:16
Efficacy of nanoliposomal irinotecan in biliary tract cancer
Hossein Taghizadeh
2:51
Impact of COVID-19 in Austria
Hossein Taghizadeh
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals